| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 09/05/2001 | EP1025088B1 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| 09/05/2001 | CN1311781A Method for prodn. of N.N-carbonyl diazoles |
| 09/05/2001 | CN1311773A Neuropeptide Y5 receptor antagonists |
| 09/05/2001 | CN1311771A Benzamidine derivative |
| 09/05/2001 | CN1311676A Compound that inhibit the binding of integrins to their receptors |
| 09/04/2001 | USH1992 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their pharmaceutical uses |
| 09/04/2001 | US6284901 Dinitrile intermediates for the synthesis of omapatrilat and methods for producing same |
| 09/04/2001 | US6284877 Sulfonamide compound and method for its production, metal chelate compound employing the sulfonamide compound, and optical recording medium employing the metal chelate compound |
| 09/04/2001 | US6284777 Carbohydrazide protease inhibitors |
| 09/04/2001 | US6284767 Retroviral protease inhibiting compounds |
| 09/04/2001 | US6284755 Inhibitors of prenyl-protein transferase |
| 08/30/2001 | WO2001062765A2 Small molecule modulators of g protein-coupled receptor six |
| 08/30/2001 | WO2001062751A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 08/30/2001 | WO2001062742A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
| 08/30/2001 | WO2001062741A1 Tetrahydronaphtalene derivatives and their use |
| 08/30/2001 | WO2001062739A2 Thioimidazolidine derivatives as light stabilizers for polymers |
| 08/30/2001 | WO2001062738A1 Novel imidazoline compounds |
| 08/30/2001 | WO2001062715A1 Novel cd23 inhibitors |
| 08/30/2001 | WO2001062713A1 Novel phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062704A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062242A1 Prodrugs of substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 08/30/2001 | WO2000071510A3 INHIBITORS OF FACTOR Xa |
| 08/30/2001 | US20010018526 Reacting alkyl halide with a pyridine compound or imidazole compound; heating in chemical reactor |
| 08/30/2001 | US20010018525 Modulating blood glucose concentration |
| 08/30/2001 | US20010018449 Hypotensive agent, endothelial damage, arteriosclerosis, antidiabetic agents |
| 08/30/2001 | CA2400659A1 Novel imidazoline compounds |
| 08/30/2001 | CA2399183A1 Thioimidazolidine derivatives |
| 08/30/2001 | CA2397234A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | CA2396971A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 08/30/2001 | CA2368447A1 Small molecule modulators of g protein-coupled receptor six |
| 08/29/2001 | EP1127880A2 Phenylacetic acid derivatives substituted by a heterocycle and their use as A-II antagonists and as inhibitors of smooth muscle cell proliferation |
| 08/29/2001 | EP1127879A1 Preparation of 2-oxo-1,3-dibenzyl-cis-4,5-imidazolidin dicarboxylic acid and its anhydrid |
| 08/29/2001 | EP0889877B1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
| 08/29/2001 | CN1310721A Medicine nitrate salts |
| 08/29/2001 | CN1310714A Substituted benzoylcyclohexandiones |
| 08/29/2001 | CN1310712A Phenylazole compound, process for producing the same and drugs for hyperlipemia |
| 08/29/2001 | CN1310709A N.N-substituted cyclic amine derivatives |
| 08/29/2001 | CN1310704A Hydroxamic acid derivatives and medicinal utilization thereof |
| 08/29/2001 | CN1310702A Nitric ester and nitrate salts of specific drugs |
| 08/29/2001 | CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
| 08/29/2001 | CN1310177A Preparation of 1,3-dibenzyl-4,5-cis-dicarboxy-2-imidazolidone as D-biotin intermediate |
| 08/29/2001 | CN1310176A Production of cyclic acid |
| 08/29/2001 | CN1309898A Pesticide containing 0-benzyl oximeether derivative and its use |
| 08/28/2001 | US6281363 Antiinflammatory agents; antiarthritic agents; autoimmune disorders |
| 08/28/2001 | US6281228 Heterocyclic inhibitors of microsomal triglyceride transfer protein and method |
| 08/28/2001 | US6280706 Chelating agents |
| 08/28/2001 | CA2017252C Retroviral protease inhibiting compounds |
| 08/25/2001 | CA2337620A1 Manufacture of a cyclic acid |
| 08/23/2001 | WO2001060822A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/23/2001 | WO2001060803A1 Fused imidazolium derivatives |
| 08/23/2001 | WO2001060802A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use as alpha-1a agonists |
| 08/23/2001 | WO2001060458A2 Inhibitors of prenyl-protein transferase |
| 08/23/2001 | WO2000071508A3 Inhibitors of factor Xa |
| 08/23/2001 | US20010016596 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/23/2001 | US20010016313 Quantitative analysis; measuring electrode potential |
| 08/23/2001 | CA2400537A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/23/2001 | CA2399147A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use as alpha-1a agonists |
| 08/22/2001 | EP1125927A1 A method for preparation of a quaternary ammonium salt |
| 08/22/2001 | EP1124824A1 Chromenone and chromanone derivatives as integrin inhibitors |
| 08/22/2001 | EP1124560A1 Use of antifungal agents for treating scleroses |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/22/2001 | CN1309645A Biphenylsulfonyl-substd. imidazole derivs., their preparation process, their use as drug or diagnostic agent |
| 08/22/2001 | CN1309644A Biphenylsulfonyl-substd. imidazole derivs., their preparation process, their use as drug or diagnostic agent and drug contg. them |
| 08/22/2001 | CN1309643A Diphenylimidazolines |
| 08/22/2001 | CN1309634A Hydrazine derivs. |
| 08/22/2001 | CN1309325A Photographic element, compound and method |
| 08/21/2001 | US6277997 Hydrogenating asymmetrically 2,5-dihydrofuran derivative in presence of catalyst comprising metal diphosphine complex to produce lactone derivative |
| 08/21/2001 | US6277987 Sulfonylamino acid and sulfonylamino hydroxamic acid derivatives |
| 08/21/2001 | US6277869 Pharmaceutical composition |
| 08/21/2001 | US6277865 Anticoagulants |
| 08/21/2001 | US6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides |
| 08/21/2001 | US6277845 Hydrazono-benzazulene derivatives, pharmaceutical compositions and intermediates |
| 08/21/2001 | US6277840 Antiinflammatory agents |
| 08/21/2001 | US6277833 3-hydroxy-3-methyl-glutaryl coenzyme a (hgm--coa) reductase inhibitors which retard cholesterol biosynthesis |
| 08/21/2001 | US6277827 Stability makes the novel species suitable for milling, compression and improved bioavailability; 2s-(4-(2, 5-dioxopyrrolidin-1-yl)-2s-mercaptobutyrylamino)-4-methylpenta noic acid (2,2-dimethyl-1s-methylcarbamoylpropyl)amide |
| 08/21/2001 | US6277559 Histamine measuring apparatus and a histamine measuring method |
| 08/21/2001 | CA2184871C Anticonvulsive 1-ar(alk)ylimidazolin-2-ones, and process for making |
| 08/21/2001 | CA2060652C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 08/21/2001 | CA2000362C Methyl .alpha.-arylacrylates substituted by a heterocyclic radical and their use |
| 08/16/2001 | WO2001058869A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 08/16/2001 | WO2001058855A1 Use of androgen receptor suppressors |
| 08/16/2001 | WO2001058854A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 08/16/2001 | WO2001058853A1 Dehydroamino acids |
| 08/16/2001 | WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 08/16/2001 | WO2001058835A1 Resolution of dl-racemic mixtures |
| 08/16/2001 | WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 08/16/2001 | WO2001009096A3 Potassium channel openers |
| 08/16/2001 | US20010014743 Procedure for producing formylimidazoles |
| 08/16/2001 | US20010014694 Hypotensive agents, stroke, vision defects, kidney disorders |
| 08/16/2001 | US20010014646 Bidentate ligands bonded to nickel, palladium, cobalt, or iron, and optionally, one or more neutral Lewis acids |
| 08/16/2001 | EP1123308A1 Single morphic forms of known peptide metalloproteinase inhibitors |
| 08/16/2001 | EP1123274A1 Substituted phenyl derivatives, their preparation and use |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 08/16/2001 | EP0953164B1 Silver-halide recording material to produce negatives with reduced fog and ultrahard-gradation |
| 08/16/2001 | DE10105944A1 Verfahren zum Herstellen optisch aktiver Hemiester A process for producing optically active hemiester |
| 08/16/2001 | DE10006694A1 New norbornenyl and 7-oxa- or 7-aza-bicyclo(2.2.1(hept-2-enyl N-heterocyclic compounds are useful as intermediates for active materials or other organic fine chemicals and in homo- and co-polymer production |
| 08/16/2001 | CA2399791A1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 08/16/2001 | CA2397993A1 Dehydroamino acids |
| 08/15/2001 | CN1308632A 'Beta'-carboline compound |
| 08/15/2001 | CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease |